Dynavax Technologies
DVAX
#5355
Rank
S$1.73 B
Marketcap
S$14.41
Share price
-0.89%
Change (1 day)
-7.20%
Change (1 year)

Operating Margin for Dynavax Technologies (DVAX)

Operating Margin as of July 2025 (TTM): 11.12%

According to Dynavax Technologies 's latest financial reports and stock price the company's current Operating Margin is 11.12%. At the end of 2024 the company had an Operating Margin of 11.13%.

Operating Margin history for Dynavax Technologies from 2003 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202411.13%-691.97%
2023-1.88%-104.62%
202240.72%130.85%
202117.64%-110.91%
2020-161.63%-62.7%
2019-433.29%-77.65%
2018-1,938.27%-93.34%
2017-29,099.08%2757.79%
2016-1,018.24%-61.38%
2015-2,636.89%220.65%
2014-822.35%-24.65%
2013-1,091.44%-9.89%
2012-1,211.24%438.71%
2011-224.84%-6.04%
2010-239.28%538.26%
2009-37.49%-42.35%
2008-65.02%-87.11%
2007-504.45%-59.79%
2006-1,254.45%717.43%
2005-153.46%34.82%
2004-113.83%-94.71%
2003-2,150.61%64.47%
2002-1,307.57%57.93%
2001-827.94%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Agenus
AGEN
-224.49%-2,118.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
17.85% 60.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
31.06% 179.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
23.75% 113.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
16.07% 44.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
13.32% 19.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
12.60% 13.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
-7.76%-169.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
19.48% 75.18%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.